Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEloxx Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Eloxx Pharmaceuticals, Inc. Earnings Date And Information
Eloxx Pharmaceuticals, Inc. last posted its earnings results on Monday, November 13th, 2023. The company reported $-1.31 earnings per share for the quarter, topping analysts' consensus estimates of $-1.97 by $0.66. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Eloxx Pharmaceuticals, Inc. has generated $-17 earnings per share over the last year ($-16.65 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Eloxx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based on prior year's report dates.
Eloxx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2023 | Q3 2023 | -$1.97 | -$1.31 | 0.66 | $0 | $0 |
| 08/11/2023 | Q2 2023 | -$1.96 | $0 | |||
| 05/12/2023 | Q1 2023 | -$2.88 | $0 | |||
| 03/31/2023 | Q4 2022 | -$2.92 | $0 | |||
| 11/10/2022 | Q3 2022 | -$4.40 | -$3.47 | 0.93 | $0 | |
| 08/12/2022 | Q2 2022 | -$4.90 | $0 | |||
| 05/06/2022 | Q1 2022 | -$3.60 | -$5.36 | -1.76 | $0 | |
| 03/30/2022 | Q4 2021 | -$5.60 | $0 | |||
| 11/08/2021 | Q3 2021 | -$4.59 | $0 | |||
| 08/16/2021 | Q2 2021 | -$5.20 | -$21.73 | -16.53 | $0 | |
| 05/07/2021 | Q1 2021 | -$8.66 | $0 | |||
| 03/12/2021 | Q4 2020 | -$6.10 | $0 | |||
| 11/06/2020 | Q3 2020 | -$6.59 | $0 | |||
| 08/07/2020 | Q2 2020 | -$7.86 | $0 | |||
| 05/08/2020 | Q1 2020 | -$13.92 | $0 | |||
| 03/06/2020 | Q4 2019 | -$11.64 | $0 | |||
| 11/06/2019 | Q3 2019 | -$12.89 | $0 | |||
| 08/07/2019 | Q2 2019 | -$14.80 | -$15.93 | -1.13 | $0 | |
| 05/09/2019 | Q1 2019 | -$16.40 | -$13.27 | 3.13 | $0 | |
| 03/14/2019 | Q4 2018 | $0.00 | $0 |
Eloxx Pharmaceuticals, Inc. Earnings: FAQ's
When is Eloxx Pharmaceuticals, Inc.'s earnings date?
Eloxx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based off last year's report dates.
Did Eloxx Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Eloxx Pharmaceuticals, Inc. (:ELOX) reported $-1.31 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.97 by $0.66.
How can I listen to Eloxx Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Eloxx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Eloxx Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Eloxx Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does Eloxx Pharmaceuticals, Inc. generate each year?
Eloxx Pharmaceuticals, Inc. (:ELOX) has a recorded net income of $0. Eloxx Pharmaceuticals, Inc. has generated $-16.65 earnings per share over the last four quarters.
What is Eloxx Pharmaceuticals, Inc.'s price-to-earnings ratio?
Eloxx Pharmaceuticals, Inc. (:ELOX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.